Histone H3.3 and cancer: A potential reader connection

被引:19
|
作者
Lan, Fei [1 ,2 ,3 ]
Shi, Yang [4 ,5 ]
机构
[1] Fudan Univ, Sch Basic Med, Shanghai Med Coll, Key Lab Epigenet,Shanghai Minist Educ, Shanghai 200032, Peoples R China
[2] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200032, Peoples R China
[3] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 201102, Peoples R China
[4] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA
关键词
histone; H3.3; H3.3K36me3; cancer; BS69; RNA-POLYMERASE-II; ADENOVIRUS E1A-ASSOCIATED PROTEIN; ACTIVATING ACVR1 MUTATIONS; INTRINSIC PONTINE GLIOMA; LYSINE; 36; TRIMETHYLATION; HIGH-GRADE GLIOMAS; VARIANT H3.3; PWWP DOMAIN; PEDIATRIC GLIOBLASTOMA; INTRON RETENTION;
D O I
10.1073/pnas.1418996111
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The building block of chromatin is nucleosome, which consists of 146 base pairs of DNA wrapped around a histone octamer composed of two copies of histone H2A, H2B, H3, and H4. Significantly, the somatic missense mutations of the histone H3 variant, H3.3, are associated with childhood and young-adult tumors, such as pediatric high-grade astrocytomas, as well as chondroblastoma and giant-cell tumors of the bone. The mechanisms by which these histone mutations cause cancer are by and large unclear. Interestingly, two recent studies identified BS69/ZMYND11, which was proposed to be a candidate tumor suppressor, as a specific reader for a modified form of H3.3 (H3.3K36me3). Importantly, some H3.3 cancer mutations are predicted to abrogate the H3.3K36me3/BS69 interaction, suggesting that this interaction may play an important role in tumor suppression. These new findings also raise the question of whether H3.3 cancer mutations may lead to the disruption and/or gain of interactions of additional cellular factors that contribute to tumorigenesis.
引用
收藏
页码:6814 / 6819
页数:6
相关论文
共 50 条
  • [1] Histone H3.3 Mutations: A Variant Path to Cancer
    Yuen, Benjamin T. K.
    Knoepfler, Paul S.
    CANCER CELL, 2013, 24 (05) : 567 - 574
  • [2] Transcription in the Absence of Histone H3.3
    Hoedl, Martina
    Basler, Konrad
    CURRENT BIOLOGY, 2009, 19 (14) : 1221 - 1226
  • [3] HISTONE H3.3 MUTATIONS ARE CANCER TYPE-SPECIFIC
    不详
    CANCER DISCOVERY, 2013, 3 (12) : 1329 - 1329
  • [4] H3.3 histone variant turnover dynamics in pluripotency and cancer
    Meshorer, E.
    FEBS OPEN BIO, 2018, 8 : 59 - 59
  • [5] Potential functions of histone H3.3 lysine 56 acetylation in mammals
    Fang, Lei
    Chen, Danqi
    Zhang, Jingzi
    Li, Hongjie
    Bradford, Beatrix
    Jin, Chunyuan
    EPIGENETICS, 2022, 17 (05) : 498 - 517
  • [6] The double face of the histone variant H3.3
    Szenker, Emmanuelle
    Ray-Gallet, Dominique
    Almouzni, Genevieve
    CELL RESEARCH, 2011, 21 (03) : 421 - 434
  • [7] H3.3 a rather special histone in the brain
    Moore, Andrew
    BIOESSAYS, 2016, 38 (05) : 407 - 407
  • [8] The double face of the histone variant H3.3
    Emmanuelle Szenker
    Dominique Ray-Gallet
    Geneviève Almouzni
    Cell Research, 2011, 21 : 421 - 434
  • [9] A DROSOPHILA-MELANOGASTER H3.3 CDNA ENCODES A HISTONE VARIANT IDENTICAL WITH THE VERTEBRATE H3.3
    FRETZIN, S
    ALLAN, BD
    VANDAAL, A
    ELGIN, SCR
    GENE, 1991, 107 (02) : 341 - 342
  • [10] Histone H1 binding is inhibited by histone variant H3.3
    Braunschweig, Ulrich
    Hogan, Greg J.
    Pagie, Ludo
    van Steensel, Bas
    EMBO JOURNAL, 2009, 28 (23): : 3635 - 3645